CLASS I Drug recall · Reported 19 Jan 2022 · FDA Enforcement Report

Clobetasol Propionate Ointment USP, 0.05% tubes recalled

Taro Pharmaceuticals U is recalling Clobetasol Propionate Ointment USP, 0.05% tubes, distributed nationwide in the US. The recall was initiated on 15 Dec 2021 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot# AC13786, exp. date DEC 2022
NDC51672-1258, 51672-1294, 51672-1259
UPC0351672129422
Quantity recalled96 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0375-2022
FDA event ID
89241
Recalling firm
Taro Pharmaceuticals U, Hawthorne, NY
Manufacturer
Sun Pharmaceutical Industries, Inc.
Classification
Class I
Status
Terminated
Recall initiated
15 Dec 2021
FDA classified
18 Jan 2022
Reported
19 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

15 Dec 2021Recall initiated by company
18 Jan 2022Classified by FDA+34 days
19 Jan 2022Published in enforcement report+1 day

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

Where it was distributed

Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.

Nationwide LouisianaUtah

Questions about this recall

Why was it recalled?

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

Which lots are affected?

Lot# AC13786, exp. date DEC 2022

Where was it sold?

Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Taro Pharmaceuticals U

All 36

Other Clobetasol Propionate recalls

All 21